[go: up one dir, main page]

UY31506A1 - Derivados de indolinona y procedimiento para su preparacion - Google Patents

Derivados de indolinona y procedimiento para su preparacion

Info

Publication number
UY31506A1
UY31506A1 UY31506A UY31506A UY31506A1 UY 31506 A1 UY31506 A1 UY 31506A1 UY 31506 A UY31506 A UY 31506A UY 31506 A UY31506 A UY 31506A UY 31506 A1 UY31506 A1 UY 31506A1
Authority
UY
Uruguay
Prior art keywords
procedure
preparation
indolinone derivatives
group
hydrogen atom
Prior art date
Application number
UY31506A
Other languages
English (en)
Inventor
Svenja Renner
Carsten Reichel
Joern Merten
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40718253&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY31506(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of UY31506A1 publication Critical patent/UY31506A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heat Sensitive Colour Forming Recording (AREA)

Abstract

La presente invencion s refiere a derivados de indolinona específicos, a saber, los compuestos de la formula en la que R1 representa un átomo de hidrogeno, o R2 y R3, tomados y conjuntamente, representan un grupo con la condicion de que cuando R1 representa un átomo de hidrogeno, R2 y R3, tomados conjuntamente representan un grupo, y a un procedimiento para su fabricacion.
UY31506A 2007-12-03 2008-12-01 Derivados de indolinona y procedimiento para su preparacion UY31506A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07122123 2007-12-03

Publications (1)

Publication Number Publication Date
UY31506A1 true UY31506A1 (es) 2009-08-03

Family

ID=40718253

Family Applications (1)

Application Number Title Priority Date Filing Date
UY31506A UY31506A1 (es) 2007-12-03 2008-12-01 Derivados de indolinona y procedimiento para su preparacion

Country Status (35)

Country Link
US (1) US8067617B2 (es)
EP (1) EP2229360B1 (es)
JP (2) JP5933924B2 (es)
KR (2) KR101712810B1 (es)
CN (1) CN101883755B (es)
AR (1) AR069531A1 (es)
AU (1) AU2008333287B2 (es)
BR (1) BRPI0819991B1 (es)
CA (1) CA2705490C (es)
CL (1) CL2008003599A1 (es)
CO (1) CO6210751A2 (es)
CY (1) CY1123333T1 (es)
DK (1) DK2229360T3 (es)
EA (1) EA016196B1 (es)
EC (1) ECSP10010195A (es)
ES (1) ES2818993T3 (es)
HR (1) HRP20201480T1 (es)
HU (1) HUE051550T2 (es)
IL (1) IL205348A (es)
LT (1) LT2229360T (es)
MA (1) MA31989B1 (es)
MX (1) MX2010005557A (es)
MY (1) MY148574A (es)
NZ (1) NZ585798A (es)
PE (1) PE20091445A1 (es)
PL (1) PL2229360T3 (es)
PT (1) PT2229360T (es)
RS (1) RS60818B1 (es)
SI (1) SI2229360T1 (es)
TN (1) TN2010000248A1 (es)
TW (1) TWI432415B (es)
UA (1) UA97872C2 (es)
UY (1) UY31506A1 (es)
WO (1) WO2009071524A2 (es)
ZA (1) ZA201002723B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20091445A1 (es) * 2007-12-03 2009-10-19 Boehringer Ingelheim Int Derivados de indolinona y procedimiento para su fabricacion
US20170065529A1 (en) 2015-09-09 2017-03-09 Boehringer Ingelheim International Gmbh Pharmaceutical dosage form for immediate release of an indolinone derivative
WO2012068441A2 (en) 2010-11-19 2012-05-24 Ratiopharm Gmbh Intedanib salts and solid state forms thereof
CN103787949A (zh) * 2012-10-31 2014-05-14 韩冰 一类保护移植器官的化合物及其用途
US20140350022A1 (en) 2013-05-10 2014-11-27 Boehringer Ingelheim International Gmbh Efficacious treatment of NSCLC and predictive clinical marker of the responsiveness of a tumour to a treatment
US20150044288A1 (en) 2013-07-31 2015-02-12 Windward Pharma, Inc. Aerosol tyrosine kinase inhibitor compounds and uses thereof
US20140342772A1 (en) * 2013-09-12 2014-11-20 Bandwidth.Com, Inc. Predictive Caching of IP Data
CN104262232B (zh) * 2014-09-09 2016-05-04 苏州明锐医药科技有限公司 尼泰达尼的制备方法
CN105712923A (zh) * 2014-12-03 2016-06-29 江苏先声药业有限公司 一种尼达尼布杂质及其制备方法与应用
WO2016178064A1 (en) 2015-05-06 2016-11-10 Suven Life Sciences Limited Polymorph of nintedanib ethanesulphonate, processes and intermediates thereof
CN105001143A (zh) * 2015-07-24 2015-10-28 南京正大天晴制药有限公司 一种制备高纯度乙磺酸尼达尼布的方法
WO2017077551A2 (en) 2015-11-03 2017-05-11 Mylan Laboratories Limited An amorphous nintedanib esylate and solid dispersion thereof
CN109415314A (zh) * 2016-05-19 2019-03-01 上海诚妙医药科技有限公司 尼达尼布的新晶型及其制备方法及其用途
CN106543069A (zh) * 2016-09-20 2017-03-29 北京万全德众医药生物技术有限公司 6‑甲氧基羰基‑2‑氧代二氢吲哚的制备
CN108610308A (zh) * 2016-12-09 2018-10-02 上海奥博生物医药技术有限公司 一锅法制备尼达尼布中间体的方法
CN106841495B (zh) * 2017-04-21 2018-05-11 常州佳德医药科技有限公司 乙磺酸尼达尼布中基因毒性杂质的高灵敏度分析方法
WO2019048974A1 (en) * 2017-09-06 2019-03-14 Glenmark Pharmaceuticals Limited Process for the preparation of nintedanib
CN111465594B (zh) 2017-11-17 2023-11-07 费米有限公司 已知作为制备尼达尼布中间体的2-吲哚满酮的合成
CN110746378B (zh) * 2018-12-03 2021-11-05 江苏豪森药业集团有限公司 一种胺基中间体的制备方法
CN111377845A (zh) * 2018-12-27 2020-07-07 江苏先声药业有限公司 3-(二甲氨基(苯基)亚甲基)-2-氧化吲哚-6-羧酸甲酯及其制备方法与应用
CN111662223B (zh) * 2019-03-08 2023-07-14 四川科伦药物研究院有限公司 二氢吲哚酮衍生物及其中间体的制备方法
US20240051920A1 (en) * 2020-08-07 2024-02-15 Bdr Lifesciences Private Limited An improved highly efficient process for the preparation of nintedanib and pharmaceutically acceptable salt thereof
CN116947732A (zh) * 2023-07-28 2023-10-27 江苏阿尔法药业股份有限公司 一种尼达尼布中间体的合成方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4876863A (es) * 1972-01-22 1973-10-16
US6469181B1 (en) * 1995-01-30 2002-10-22 Catalytica, Inc. Process for preparing 2-oxindoles and N-hydroxy-2-oxindoles
GB9516943D0 (en) * 1995-08-18 1995-10-18 Cancer Soc Auckland Div Nz Inc Novel cyclopropylindoles and their secoprecursors,and their use as prodrugs
DE59906030D1 (de) 1998-09-25 2003-07-24 Boehringer Ingelheim Pharma Neue substituierte indolinone mit einer inhibierenden wirkung auf verschiedene kinasen und cyclin/cdk-komplexe
US7291641B2 (en) * 1999-10-11 2007-11-06 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
UA75054C2 (uk) * 1999-10-13 2006-03-15 Бьорінгер Інгельхайм Фарма Гмбх & Ко. Кг Заміщені в положенні 6 індолінони, їх одержання та їх застосування як лікарського засобу
DE10117204A1 (de) * 2001-04-06 2002-10-10 Boehringer Ingelheim Pharma In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
DE10233500A1 (de) * 2002-07-24 2004-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylen]-6-methoxycarbonyl-2-indolinon-Monoethansulfonat und dessen Verwendung als Arzneimittel
US7148249B2 (en) 2002-09-12 2006-12-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments
JP4623604B2 (ja) * 2006-11-06 2011-02-02 株式会社セラバリューズ 新規なオキシインドール誘導体
RU2525114C2 (ru) * 2007-12-03 2014-08-10 Бёрингер Ингельхайм Интернациональ Гмбх Способ получения производного индолинона
PE20091445A1 (es) * 2007-12-03 2009-10-19 Boehringer Ingelheim Int Derivados de indolinona y procedimiento para su fabricacion

Also Published As

Publication number Publication date
LT2229360T (lt) 2020-10-12
ECSP10010195A (es) 2010-07-30
CO6210751A2 (es) 2010-10-20
EA016196B1 (ru) 2012-03-30
ZA201002723B (en) 2010-12-29
EA201000883A1 (ru) 2010-12-30
TWI432415B (zh) 2014-04-01
ES2818993T3 (es) 2021-04-14
KR101676261B1 (ko) 2016-11-15
HUE051550T2 (hu) 2021-03-01
HRP20201480T1 (hr) 2020-12-11
PL2229360T3 (pl) 2020-12-14
BRPI0819991A2 (pt) 2015-05-12
EP2229360A2 (en) 2010-09-22
CA2705490C (en) 2016-02-02
UA97872C2 (ru) 2012-03-26
US8067617B2 (en) 2011-11-29
WO2009071524A2 (en) 2009-06-11
JP2015071602A (ja) 2015-04-16
MY148574A (en) 2013-04-30
TN2010000248A1 (fr) 2011-11-11
SI2229360T1 (sl) 2020-11-30
IL205348A (en) 2014-06-30
DK2229360T3 (da) 2020-09-28
EP2229360B1 (en) 2020-07-01
CL2008003599A1 (es) 2010-08-20
KR20100097129A (ko) 2010-09-02
PE20091445A1 (es) 2009-10-19
CN101883755A (zh) 2010-11-10
KR101712810B1 (ko) 2017-03-07
IL205348A0 (en) 2010-12-30
CA2705490A1 (en) 2009-06-11
AU2008333287A1 (en) 2009-06-11
KR20150116909A (ko) 2015-10-16
JP2011505346A (ja) 2011-02-24
JP6044025B2 (ja) 2016-12-14
MX2010005557A (es) 2010-06-01
TW200930702A (en) 2009-07-16
AU2008333287B2 (en) 2013-12-19
CN101883755B (zh) 2013-06-26
CY1123333T1 (el) 2021-12-31
AR069531A1 (es) 2010-01-27
MA31989B1 (fr) 2011-01-03
JP5933924B2 (ja) 2016-06-15
NZ585798A (en) 2011-06-30
PT2229360T (pt) 2020-09-15
BRPI0819991B1 (pt) 2022-02-15
US20100311985A1 (en) 2010-12-09
WO2009071524A3 (en) 2009-10-01
HK1145682A1 (en) 2011-04-29
RS60818B1 (sr) 2020-10-30

Similar Documents

Publication Publication Date Title
UY31506A1 (es) Derivados de indolinona y procedimiento para su preparacion
CR11241A (es) Compuestos de pirazol y su uso como inhibidores de raf
MX2019003738A (es) Compuestos antivirales.
UY31611A1 (es) Compuestos que comprenden un grupo ciclobutoxi
CO6400230A2 (es) Conjugados de insulina cristalina
ECSP11011139A (es) Anticuerpos contra la angiopoyetina 2 humana
ECSP14013245A (es) Nuevos derivados dihidroquinolina-2-ona
CR20120184A (es) Anticuerpos monoclonales frente a progastrina y su usos
DOP2010000396A (es) Derivado de uracilo o timina para el tratamiento de hepatitis c
ECSP11011390A (es) Compuestos espiro-amidas sustituidas
MX2009013354A (es) Compuestos de triarilo y composiciones que los contienen.
CR20110286A (es) Proceso para la preparacion de derivados de l-alanina protegidos
AR081819A1 (es) Derivados de pirimidil-piperidinil-oxipiridinona, composiciones farmaceuticas que los contienen y uso de los mismos para tratar diabetes, dislipemias, obesidad y otras enfermedades
UY29742A1 (es) Procedimiento para la preparación de betamimeticos
EA200702464A1 (ru) Способы получения фенольных 4-бифенилилазетидин-2-онов
HN2006037713A (es) Compuestos utiles en terapia
GT200600144AA (es) 1h-quinazolin-2,4-dionas (solicitud fraccionaria, derivada de la solicitud de patente de invencion pi-2006-00144)
PA8796801A1 (es) Sintesis quiral de diazepinoquinolinas
CR9565A (es) Derivados del 4,5-diarilpirrol, su preparacion y su aplicacion en terapeutica
UY31487A1 (es) Derivados de pirazol como inhibidores de 5-lo
CR20110111A (es) Composicion farmaceutica solida
UY32101A (es) Compuestos de triazol, su uso, así como productos que los contienen
AR058253A1 (es) Procedimiento para la preparacion de ferri-succinilcaseina
CR10969A (es) Derivados de azabicicloalcano, su preparacion y su aplicacion en terapeutica
PA8728901A1 (es) Metodos para preparar derivados de acido glutamico e intermediarios del mismo

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20190528